|
MECHLORETHAMINE
 INN MECHLORETHAMINE
|
cas 51-75-2 |
CLASS ANTINEOPLASTIC ALKYLATING AGENTS TREATMENT OF HODGKIN'S DISEASE UNDERGOES RAPID CHEMICAL TRANSFORMATION THE DRUG IS NO LONGER PRESENT IN ACTIVE FORM A FEW MINUTES AFTER ADMINISTRATION |
ROUTE ( list) INJECTION TOPICAL |
ATC code
L01AA05 |
SolubilityVERY SOLUBLE IN WATER
|
Target TARGET DNA |
DrugCentral Unknown |
Download SDF file |
2-chloro-N-(2-chloroethyl)-N-methylethanamine Formula: C5H11Cl2N Calculated chemical properties: MW 156.05 NB_atoms 8 XLogP 1.40 PSA 5.671 NB_HD 0 NB_HA 1 fsp3 1.00 Lipinski(0=no;1=yes) 1 |
FDA NDA 006695 ( label) INN (MECHLORETHAMINE HYDROCHLORIDE) MUSTARGEN (RECORDATI RARE) APPROVAL= AP YEAR= 1949 DISCONTINUED NDA 202317 ( label) INN (MECHLORETHAMINE HYDROCHLORIDE) VALCHLOR (HELSINN) APPROVAL= AP YEAR= 2013 |
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |